ALK and neuroblastoma: CCC-003 treatment upregulated apoptotic cell death in neuroblastoma cells and tumor tissues, suggesting that the suppression of oncogenic mutated ALK by CCC-003 was sufficient to upregulate pro-apoptotic signaling and thus exert anti-tumor effects in ALK-positive neuroblastoma.